Form 4 for CTEV Claritev Corp

Accepted 2025-03-04 00:00:00 ET · period of report 2025-03-01 · accession 0001793229-25-000042 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2025-03-04	2025-03-01	CTEV	Mintz William B.	SVP, Corp. Affairs, Strategy	A - Grant	$0.00	+12.9K	68.0K	+23%	$0
D	2025-03-04	2025-03-01	CTEV	Mintz William B.	SVP, Corp. Affairs, Strategy	A - Grant	$0.00	+12.9K	12.9K	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Class A common stock	2025-03-01	A	A	12,863	$0.00	68,031	D	—	—
2	Derivative	Cash Settled Restricted Stock Units	2025-03-01	A	A	12,863	$0.00	12,863	D	— · — to —	12,863 Class A common stock, par value $0.0001 per share	(F2) Represents cash settled restricted stock units (cRSUs) vesting 50%/year on March 1, 2026 and 2027. Each cRSU is the economic equivalent of a share of Class A common stock (the Common Stock) of Claritev Corp. (the Company) and will be settled in cash based on the fair market value (FMV) per share of the Common Stock at settlement, subject to a cap of 4x the FMV of a share of Common Stock on the grant date (the cap) if settled prior to a change in control (CiC) of the Company (as defined in the award agreement). If settled at the cap, the Reporting Person will become entitled to receive a payment per cRSU equal to the lesser of, if positive, (i) the price per share received by the Company's stockholders in the CiC and (ii) the FMV of a share of Common Stock at the original settlement date, less the cap, if a CiC occurs on or prior to the 5th anniversary following the grant date. Any such excess will be paid on the earlier of the 5th anniversary of the grant date and certain CiCs.